Paindrainer is a digital therapeutics (DTx) company developing digital platforms and applications contributing to health and well-being. PD Care System is the first evidence based digital tool demonstrating improved quality of life in patients suffering from chronic pain.

“Having completed a share issue transaction in the current market with support from both existing and new owners feels fantastic. It shows the growing interest in these types of third-generation digital companies, and it enables us to continue our highly important commercialization and start to grow our operations”

says Erik Frick, CEO Paindrainer.

The solution is powered by a proprietary Artificial Neural Network (ANN) and is fully adaptive to each chronic pain patient, demonstrating our unique and patented 360 patient-centricity concept. Key concepts of this device has now been implemented into an agentic AI powering our newest product, Relivra, that will reach the market during Q2 2026.

The use of proceeds focuses on Paindrainer continued successful commercial rollout in the US of the unique drug-free, digital remote therapeutic monitoring system for chronic pain patients, using the proprietary AI powered neural network. It also enables the company to commercialize the newest product, Relivra, directed to pain Organization in a number of selected markets.

The post Paindrainer raises €500K for AI Digital Therapeutics appeared first on Øresund Startups.

The funds will be used to drive the commercial rollout of Paindrainer’s groundbreaking, drug-free, digital remote therapeutic monitoring system for chronic pain patients in the US. This system utilizes a proprietary AI-powered neural network to deliver personalized care. Additionally, the investment will support ongoing clinical trials with top-tier health organizations and the development of new functionalities for the digital tool.

“Having completed a share issue transaction in the current market with support from both existing and new owners feels fantastic. It shows the growing interest in these types of second-generation digital companies, and it enables us to increase our presence in the highly important US market with our remote therapeutic monitoring solution,”

said Erik Frick, CEO of Paindrainer

The company welcomes two new anchor investors, who will support Paindrainer’s commercial journey.

“I am excited to join Paindrainer as an engaged shareholder in its journey towards helping chronic pain patients increase their quality of life,”

Fredrik Sjödin, CEO of Tramontane Invest, said.

Paindrainer is developing digital platforms and applications that enhance health and well-being. Their flagship Paindrainer app is the first evidence-based digital tool proven to improve the quality of life for chronic pain patients. The solution is powered by a proprietary Artificial Neural Network (ANN) and is fully adaptive to each patient, embodying Paindrainer’s unique and patented 360° patient-centricity concept.

“We are thrilled to support Paindrainer as they continue their mission to improve chronic pain management. Their patient-centric approach aligns with our vision of investing in innovative solutions that make a real difference. We look forward to supporting their expansion and impact in the US and beyond.”

said Joel Gardestrand, Investment Manager at ReThink Capital

The post Paindrainer Raises €800K and Expands in the US appeared first on Øresund Startups.

The funding boost will enable the company to launch their innovative digital self-management tool for chronic pain patients without drugs. In addition, it will enable the company to speed up the incorporation of wearables into the product, resulting in greater patient convenience, engagement, and accuracy of input data.

“Having achieved outstanding clinical evidence, commercialization of Paindrainer is our top priority in 2023. There is a high demand for drug-free remote therapeutic monitoring products in the USA and it provides a great opportunity to enter the US market and partner with clinics directly.”

says Erik Frick, CEO Paindrainer

Paindrainer is blazing a trail in the healthcare industry by harnessing the power of digital therapeutics (DTx). Their flagship product, the Paindrainer App, is a groundbreaking, evidence-based digital tool that employs an advanced Artificial Neural Network (ANN) to provide a fully personalised and patient-centered approach to chronic pain management.

The post Paindrainer secured funding for AI based chronic pain management app appeared first on Øresund Startups.

PrainDrainer has developed cloud-based applications for self-management of chronic pain, using multilevel Artificial Intelligent Systems being worked on in White Sands rehab Orlando FL. According to themselves, the product is the first drug free, self-management tool identification of each patient’s pain triggers and pain protectors, allowing the patient to increase the quality of life, based on the personal analysis and prognosis by AI. Although only one year has passed since they founded the company, they are already at the stage to start clinical studies.

“Hopefully we can launch to consumers already next year. It’s the fastest project I’ve been involved in”, says Carl Borrebaeck to Rapidus.

PainDrainer was founded in 2018 led by Professor Carl Borrebaeck, together with IT entrepreneur Göran Barkfors and researcher Maria Klement. Göran is an experienced entrepreneur who has previously founded Nasdaq-listed Immunovia, Alligator Bioscience and Senzagen among others. The startup has also an advisory board consisting of clinical pain management expert Christer Carlsson and AI specialist Mattias Ohlsson.

They have raised € 600.000 (SEK 6.7 millions) from nine investors including profile investor Christian W Jansson. The money will be invested in hiring staff to start up the business seriously after the clinical trials, and invest in digital marketing. In addition, for the further expansion, the company will move to new premises in Medicon Village in September.

“So far we have only been a bunch of enthusiasts who have worked on this, but now we are going to get started really”, says Carl

The post eHealth startup PainDrainer secures funding from angels appeared first on Øresund Startups.